The curative effect of Diquafosol Sodium ophthalmic solution 3% to the diabetic who has the amount fall of tear fluid secretion, and an anterior-epithelium-of-cornea obstacle. - The curative effect of Diquafosol Sodium ophthalmic solution 3% to the diabetic who has the amount fall of tear fluid secretion, and an anterior-epithelium-of-cornea obstacle.

Tokyo Women's Medical University School of Medicine0 sites45 target enrollmentJune 10, 2013

Conditionsdiabetes with an anterior-epithelium-of-cornea obstacle

Overview

Phase: 未知
Intervention: Not specified
Conditions: diabetes with an anterior-epithelium-of-cornea obstacle
Sponsor: Tokyo Women's Medical University School of Medicine
Enrollment: 45
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

June 10, 2013

End Date

March 31, 2016

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Tokyo Women's Medical University School of Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\.The user of a contact lens (used within one week or the existing patient who is going to use a contact lens during medical treatment observation) 2\.The patient who has the past of cornea refractive surgery. 3\.The patient currently diagnosed as meibomian gland dysfunction. 4\.The patient suffered from eye infection or a serious allergic conjunctival disease. 5\.The patient currently diagnosed as the cicatricial angle conjunctival disease (eye pemphigoid, and Stevens\-Johnson syndrome and alkali externally caused injury are included). 6\.The patient who has the past of an inner eye operation (laser surgery is included) within three months before an observation start. 7\.The patient who was continuing the medical treatment (a punctum plug insertion way, a surgical punctum closing way, etc.) aiming at the blockade of punctum before the observation term start till less than one month. 8\.The patient who is performing dry eye auxiliary medical treatment which has on pharmacometrics, such as glasses for dry eye protection. 9\.The patient who has eyeblink insufficiency. 10\.The patient who has a schedule which adds an applying\- ophthalmic solution during exam. 11\.The patient with the schedule which uses the medicine (treatment) provided in the regulation about a concomitant drug (treatment) during exam. 12\.The patient who had complications of the heart, liver, the kidney, blood dyscrasia, and others, and was judged to be unsuitable on pharmacometrics. 13\.The patient who there is under pregnancy and breast\-feeding or a possibility of having become pregnant, or wishes to become pregnant within one month after the scheduled end of an observation period.